🎉 M&A multiples are live!
Check it out!

Laurus Labs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Laurus Labs and similar public comparables like Benevolent AI, Julphar, and Galapagos.

Laurus Labs Overview

About Laurus Labs

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.


Founded

2005

HQ

India
Employees

6.0K+

Website

lauruslabs.com

Financials

LTM Revenue $642M

LTM EBITDA $122M

EV

$4.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Laurus Labs Financials

Laurus Labs has a last 12-month revenue of $642M and a last 12-month EBITDA of $122M.

In the most recent fiscal year, Laurus Labs achieved revenue of $581M and an EBITDA of $92.1M.

Laurus Labs expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Laurus Labs valuation multiples based on analyst estimates

Laurus Labs P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $699M $581M XXX XXX XXX
Gross Profit $307M $369M XXX XXX XXX
Gross Margin 44% 63% XXX XXX XXX
EBITDA $181M $92.1M XXX XXX XXX
EBITDA Margin 26% 16% XXX XXX XXX
Net Profit $96.1M $91.8M XXX XXX XXX
Net Margin 14% 16% XXX XXX XXX
Net Debt $192M $224M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Laurus Labs Stock Performance

As of April 15, 2025, Laurus Labs's stock price is INR 606 (or $7).

Laurus Labs has current market cap of INR 327B (or $3.8B), and EV of INR 354B (or $4.1B).

See Laurus Labs trading valuation data

Laurus Labs Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.1B $3.8B XXX XXX XXX XXX $0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Laurus Labs Valuation Multiples

As of April 15, 2025, Laurus Labs has market cap of $3.8B and EV of $4.1B.

Laurus Labs's trades at 6.4x LTM EV/Revenue multiple, and 33.8x LTM EBITDA.

Analysts estimate Laurus Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Laurus Labs and 10K+ public comps

Laurus Labs Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $4.1B XXX XXX XXX
EV/Revenue 6.6x XXX XXX XXX
EV/EBITDA 36.5x XXX XXX XXX
P/E 119.4x XXX XXX XXX
P/E/Growth 1.8x XXX XXX XXX
EV/FCF 435.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Laurus Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Laurus Labs Valuation Multiples

Laurus Labs's NTM/LTM revenue growth is 17%

Laurus Labs's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $41K for the same period.

Over next 12 months, Laurus Labs's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Laurus Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Laurus Labs and other 10K+ public comps

Laurus Labs Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -17% XXX XXX XXX XXX
EBITDA Margin 18% XXX XXX XXX XXX
EBITDA Growth -49% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 35% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $41K XXX XXX XXX XXX
S&M Expenses to Revenue 3% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 42% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Laurus Labs Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Laurus Labs M&A and Investment Activity

Laurus Labs acquired  XXX companies to date.

Last acquisition by Laurus Labs was  XXXXXXXX, XXXXX XXXXX XXXXXX . Laurus Labs acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Laurus Labs

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Laurus Labs

When was Laurus Labs founded? Laurus Labs was founded in 2005.
Where is Laurus Labs headquartered? Laurus Labs is headquartered in India.
How many employees does Laurus Labs have? As of today, Laurus Labs has 6.0K+ employees.
Who is the CEO of Laurus Labs? Laurus Labs's CEO is Dr. Satyanarayana Chava.
Is Laurus Labs publicy listed? Yes, Laurus Labs is a public company listed on BOM.
What is the stock symbol of Laurus Labs? Laurus Labs trades under 540222 ticker.
When did Laurus Labs go public? Laurus Labs went public in 2016.
Who are competitors of Laurus Labs? Similar companies to Laurus Labs include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Laurus Labs? Laurus Labs's current market cap is $3.8B
What is the current revenue of Laurus Labs? Laurus Labs's last 12-month revenue is $642M.
What is the current EBITDA of Laurus Labs? Laurus Labs's last 12-month EBITDA is $122M.
What is the current EV/Revenue multiple of Laurus Labs? Current revenue multiple of Laurus Labs is 6.4x.
What is the current EV/EBITDA multiple of Laurus Labs? Current EBITDA multiple of Laurus Labs is 33.8x.
What is the current revenue growth of Laurus Labs? Laurus Labs revenue growth between 2023 and 2024 was -17%.
Is Laurus Labs profitable? Yes, Laurus Labs is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.